fulvestrant has been researched along with 5-methylcytosine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balasubramanian, S; Broome, R; Carroll, JS; Chernukhin, I; D'Santos, C; Farcas, AM; Groen, AJ; Jamieson, S; Kishore, K; Mahtey, A; Mao, SQ; Papachristou, EK; Siersbæk, R; Tejedo, CG; Theodorou, V | 1 |
| Argueta, C; Li, S; Liu, L; Lyu, R; Shen, Y; Tan, L; Xiong, L; Zhu, X | 1 |
2 other study(ies) available for fulvestrant and 5-methylcytosine
| Article | Year |
|---|---|
TET2 is a component of the estrogen receptor complex and controls 5mC to 5hmC conversion at estrogen receptor cis-regulatory regions.
Topics: 5-Methylcytosine; Animals; Breast Neoplasms; Chromatin Assembly and Disassembly; Databases, Genetic; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Enhancer Elements, Genetic; Estrogen Receptor alpha; Estrogen Receptor Antagonists; Female; Fulvestrant; GATA3 Transcription Factor; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Mice, Inbred NOD; Mice, SCID; Xenograft Model Antitumor Assays | 2021 |
Regulation of TET2 gene expression and 5mC oxidation in breast cancer cells by estrogen signaling.
Topics: 5-Methylcytosine; Breast Neoplasms; Cell Line, Tumor; Dioxygenases; DNA-Binding Proteins; Down-Regulation; Enhancer Elements, Genetic; Estradiol; Estrogen Receptor alpha; Estrogens; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Oxidation-Reduction; Protein Binding; Signal Transduction; Transcription, Genetic | 2022 |